Project title: Molecular mapping of genome instability and carcinogenesis, MolMedEx TUMORDNA
Funding source: ITM, EU
Period: 2016-2020
Amount (in Euros): 349 472
Role of the Principal investigator: He is the principal investigator in this grant
Project title: Molecular analysis of transposon-mediated gene transfer for a safer gene therapy
Funding source: ITM, EU
Period: 2016-2020
Amount (in Euros): 489 050
Role of the Principal investigator: Consortium member
Project title: How do the genotype and the environment of cells determine their observable characteristics? System-level microfluidical analysis with the iChamber platform.
Funding source: EU
Period: 2016-2020
Amount (in Euros): 304 538
Role of the Principal investigator: Consortium member
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.
